drugset / Trial / NCT00239135
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is : * To determine the maximum tolerated dose (MTD) for PEP005 Topical Gel in patients with actinic keratoses. * To evaluate patients for clinical safety * To determine the systemic absorption of PEP005 Topical Gel
Timeline
- Start
- 2005-09
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ingenol mebutate | Small molecule | 0.01 % | Topical |